Natera

Yahoo Finance • 4 days ago

Stanley Druckenmiller Loaded Up on This Stock That’s Down 77%

Quick Read Sea (SE) surged 244.3% in Druckenmiller’s portfolio to 944k shares worth $120M, now constituting 2.85% of his holdings, as the company trades at just 10x free cash flow despite 17.2% three-year revenue growth and 10x profit exp... Full story

Yahoo Finance • 9 days ago

Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as investors reacted to escalating uncertainty tied to the U.S.-Iran conflict and poli... Full story

Yahoo Finance • 20 days ago

NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after easing crude oil prices helped lift investor sentiment and reduce inflation worries. The retreat in oil prices provided temporary relief to a market that was volatil... Full story

Yahoo Finance • 20 days ago

3 Growth Stocks to Add to Your Roster

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle. Luckily for you, our job at StockStory is to h... Full story

Yahoo Finance • 20 days ago

This Biotech Stock Surged 75% Last Quarter and Pulled a New $9 Million Investment

Key Points Eversept Partners added 264,468 shares of Vera Therapeutics in the fourth quarter; the estimated transaction value was $9.39 million based on quarterly average pricing. Meanwhile, the quarter-end position value increased in val... Full story

Yahoo Finance • 25 days ago

Citi Flags Agilent Technologies, Cuts Icon PLC Target, and More

Quick Read Citi is positioning selectively across life sciences by favoring recovery names with clear catalysts while avoiding companies navigating accounting uncertainty, with Agilent’s pending Biocare deal removal expected to drive mult... Full story

Yahoo Finance • 27 days ago

3 Healthcare Stocks to Target This Week

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have seen decent returns lately as healthcare stocks were up 5.7% over the past six month... Full story

Yahoo Finance • last month

Signatera Oncology Test Drives Natera’s (NTRA) Growth

Carillon Tower Advisers, an investment management company, released its fourth-quarter 2025 investor letter for the “Carillon Eagle Mid Cap Growth Fund”. A copy of the letter can be downloaded here. The fourth quarter of 2025 saw mixed res... Full story

Yahoo Finance • last month

Natera: Q4 Earnings Snapshot

AUSTIN, Texas (AP) — AUSTIN, Texas (AP) — Natera Inc. (NTRA) on Thursday reported fourth-quarter net income of $47.3 million. On a per-share basis, the Austin, Texas-based company said it had net income of 35 cents. The results topped Wa... Full story

Yahoo Finance • last month

Billionaire Stanley Druckenmiller Is Betting Big on These 2 Stocks

Key Points One investment is a fast-growing genetic testing company that's now generating cash flow and has a scalable business model. The leading semiconductor foundry's sales are booming on AI-led demand, but expanding cash-flow margin... Full story

Yahoo Finance • 2 months ago

Philippe Laffont's Strategic Exit from CoreWeave Inc: A -2.26% Portfolio Impact

This article first appeared on GuruFocus. Insights into Philippe Laffont (Trades, Portfolio)'s Fourth Quarter 2025 Investment Moves Warning! GuruFocus has detected 9 Warning Signs with BHP. Is TSM fairly valued? Test your thesis with our... Full story

Yahoo Finance • 2 months ago

Stanley Druckenmiller's Strategic Moves: A Closer Look at State Street Financial Select Sector ...

This article first appeared on GuruFocus. Insights from the Fourth Quarter 2025 13F Filing Stanley Druckenmiller (Trades, Portfolio) recently submitted his 13F filing for the fourth quarter of 2025, revealing strategic investment decisio... Full story

Yahoo Finance • 3 months ago

Natera (NTRA) Announces Publication of Findings from Randomized, Phase III CALGB (Alliance)/SWOG 80702 Study

Natera, Inc. (NASDAQ:NTRA) is one of the High Growth Large Cap Stocks to Buy Right Now.On December 18, the company announced publication of the findings from the randomized, phase III CALGB (Alliance)/SWOG 80702 study in JAMA Oncology. CAL... Full story

Yahoo Finance • 3 months ago

Natera to Participate in the 44th Annual J.P. Morgan Healthcare Conference

AUSTIN, Texas, December 22, 2025--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it will participate in the 44th Annual J.P. Morgan Healthcare Conference in San F... Full story

Yahoo Finance • 4 months ago

Liberty All-Star® Growth Fund, Inc. November 2025 Monthly Update

BOSTON, December 15, 2025--(BUSINESS WIRE)--Below is the November 2025 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE: ASG). Liberty All-Star Growth Fund, Inc. Ticker: ASG Monthly Update, November 2025 Investment Approa... Full story

Yahoo Finance • 4 months ago

SPYM, DRKY: Big ETF Inflows

Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel, the biggest inflow was seen in the State Street Investment Management, which added 27,150,000 units, or a 2.2% increase week over week. Among... Full story

Yahoo Finance • 4 months ago

Billionaire Stanley Druckenmiller is Betting $1.2 Billion in These 3 Stocks

Neilson Barnard / Getty Images Entertainment via Getty Images Quick Read Natera (NTRA) grew revenue 34.66% year-over-year in Q3 2025 and has rallied nearly 70% since Q3 2025. Druckenmiller holds $517.4M in Natera. Insmed (INSM) revenue s... Full story

Yahoo Finance • 4 months ago

Natera Unveils MRD Data From Phase III PALLAS Trial In HR+/HER2- Breast Cancer

(RTTNews) - Natera Inc. (NTRA) announced initial translational research results from the international randomized Phase III PALLAS study. The findings were presented at the San Antonio Breast Cancer Symposium (SABCS) and highlight the prog... Full story

Yahoo Finance • 4 months ago

New Amazon Bedrock AgentCore Capabilities Power the Next Wave of Agentic AI Development

Latest AgentCore innovations help customers build, deploy, and scale production-ready AI agents with confidence LAS VEGAS, December 02, 2025--(BUSINESS WIRE)--At AWS re:Invent, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company... Full story

Yahoo Finance • 4 months ago

30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 3 Biotech Stocks

Key Points Druckenmiller invests his personal and family's wealth through his fund, the Duquesne Family Office. Druckenmiller is high on biotech stocks, with his top three holdings at the end of the third quarter all in the sector. Biotec... Full story